Following a scientific review of the safety of pholcodine, the Medicines and Healthcare products Regulatory Agency (MHRA), with advice from the independent Commission on Human Medicines, has recommended that all pholcodine-containing cough and cold medicines should be withdrawn as a precautionary measure. 

The Affidia Journal will be hosting an online webinar entitled Precautionary Allergen Labelling (PAL): What lies ahead on 23 March, 3 – 5pm.

For many people, Easter is the time of year for indulging in chocolate and all kinds of other sweet treats.

We are moving our AllergyWise® courses to our new learning platform on the Anaphylaxis UK website. The new platform provides a smoother training experience and features our updated and improved AllergyWise® for Schools course. 

Anaphylaxis UK is urging healthcare professionals to make sure that medication prescribed to their patients does not contain ingredients that they are allergic too.  

Jo talks about her struggles with avoiding contact with latex gloves and rubber while on duty and how this impacted her ability to do her job. She shares how she developed the allergy in her late 20s, despite having no prior history of a serious allergy.

A review of recent data regarding frequency of allergic reactions has shown similar rates of anaphylaxis to COVID vaccines as to other vaccines.  

The Food Standards Agency (the food regulator for England, Northern Ireland and Wales) want to understand the experiences of people who have had reactions to food or drinks or have narrowly avoided having a reaction.

The Patient Information Forum (PIF) has today (28 February) launched a new PIF TICK toolkit to help healthcare professionals provide trusted information to their patients.